Argobio operates as a startup incubator located in the city of Paris, in the nation of France, specializing in transforming cutting-edge advancements into pioneering biotech firms. The company actively seeks out innovative early-stage initiatives in therapeutics from esteemed academic research institutions across Europe, emphasizing rare diseases, neurological disorders, oncology, and immunology. After careful selection, Argobio nurtures and develops these initiatives with the aim of establishing viable biotech enterprises and guiding them through substantial Series A funding rounds. The organization offers extensive proficiency in discovering and creating new pharmaceuticals, leveraging a team of seasoned Biotech entrepreneurs.